MM Healthcare Ltd 11852081 false 2023-07-01 2024-06-30 2024-06-30 The principal activity of the company is mobility specialists Digita Accounts Production Advanced 6.30.9574.0 true true 11852081 2023-07-01 2024-06-30 11852081 2024-06-30 11852081 core:CurrentFinancialInstruments 2024-06-30 11852081 core:CurrentFinancialInstruments core:WithinOneYear 2024-06-30 11852081 bus:SmallEntities 2023-07-01 2024-06-30 11852081 bus:AuditExemptWithAccountantsReport 2023-07-01 2024-06-30 11852081 bus:FilletedAccounts 2023-07-01 2024-06-30 11852081 bus:SmallCompaniesRegimeForAccounts 2023-07-01 2024-06-30 11852081 bus:RegisteredOffice 2023-07-01 2024-06-30 11852081 bus:Director1 2023-07-01 2024-06-30 11852081 bus:Director2 2023-07-01 2024-06-30 11852081 bus:PrivateLimitedCompanyLtd 2023-07-01 2024-06-30 11852081 countries:England 2023-07-01 2024-06-30 11852081 2022-03-01 2023-06-30 11852081 2023-06-30 11852081 core:CurrentFinancialInstruments 2023-06-30 11852081 core:CurrentFinancialInstruments core:WithinOneYear 2023-06-30 iso4217:GBP xbrli:pure

Registration number: 11852081

MM Healthcare Ltd

Unaudited Filleted Financial Statements

for the Year Ended 30 June 2024

 

MM Healthcare Ltd

Contents

Company Information

1

Balance Sheet

2 to 3

Notes to the Unaudited Financial Statements

4 to 6

 

MM Healthcare Ltd

Company Information

Directors

M Sampson

D Leach

Registered office

Victoria Court
91 Huddersfield Road
Holmfirth
West Yorkshire
HD9 3JA

 

MM Healthcare Ltd

(Registration number: 11852081)
Balance Sheet as at 30 June 2024

Note

2024
£

2023
£

Current assets

 

Stocks

4

258,667

133,965

Debtors

5

2,298,687

722,373

Cash at bank and in hand

 

920,552

293,752

 

3,477,906

1,150,090

Creditors: Amounts falling due within one year

6

(2,168,136)

(491,705)

Net assets

 

1,309,770

658,385

Capital and reserves

 

Called up share capital

1

1

Retained earnings

1,309,769

658,384

Shareholders' funds

 

1,309,770

658,385

 

MM Healthcare Ltd

(Registration number: 11852081)
Balance Sheet as at 30 June 2024

For the financial year ending 30 June 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 30 August 2024 and signed on its behalf by:
 

.........................................
M Sampson
Director

 

MM Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

1

General information

The company is a private company limited by share capital, incorporated in England.

These financial statements were authorised for issue by the Board on 30 August 2024.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

 

MM Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 0 (2023 - 0).

 

MM Healthcare Ltd

Notes to the Unaudited Financial Statements for the Year Ended 30 June 2024

4

Stocks

2024
£

2023
£

Other inventories

258,667

133,965

5

Debtors

Current

2024
£

2023
£

Trade debtors

13,001

141,173

Other debtors

2,285,686

581,200

 

2,298,687

722,373

6

Creditors

Creditors: amounts falling due within one year

Note

2024
£

2023
£

Due within one year

 

Trade creditors

 

29,828

121,978

Amounts owed to group undertakings and undertakings in which the company has a participating interest

7

1,679,973

-

Taxation and social security

 

445,798

330,470

Accruals and deferred income

 

1,820

1,820

Other creditors

 

10,717

37,437

 

2,168,136

491,705

7

Related party transactions

Transactions with directors

Directors' remuneration

The directors' remuneration for the year was as follows:

2024
£

2023
£

Remuneration

8,628

-